Kwatra SG, Yosipovitch G, Mollanazar NK, Stander S, Kim BS, Hong HC, Msihid J, Bansal A, O'Malley TJ, Bahloul D, Thomas RB Dupilumab Improves Multiple Factors Impacting Quaility of Life in Adults With Prurigo Nodulras (LIBERTY-PN PRIME and PRIME2) , CDA Annual Conference: 2023
Yosipovitch G, Mollanazar NK, Stander S, Kwatra SG, Kim BS, Laws E, Mannent LP, Amin N, Akinlade, Staudinger H, Patel N, Yancopoulos GD, Weinreich DM, Wang S, Shi G, Bansal A, O'Malley JT Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials , Nat Med, 29(5): 2023,1180-90
Florez A, Yosipovitch G, Kwatra SG, Mollanazar N, Stander S Satoh T, Laws E, Mannent LP, Mortensen E, Maloney J, Shi G, Bansal, Martincova R Dupilumab Significantly Improves Itch and Skin Lesions in Patients With Prurigo Nodulras: Pooled Results From Two Phase 3 Trails (LIBERTY-PN PRIME and PRIME 2) , Academia Espnola de Dermatologia y Venereologia (AEDV): 2023
Kwatra SG, Yosipovitch G, Mollanazar NK, Stander S, Kim BS, Msihid J, Bansal A, O'Malley TJ, Bahloul D, Thomas RB Dupilumab Improves Multiple Factors Impacting Quaility of Life in Adults With Prurigo Nodulras (LIBERTY-PN PRIME and PRIME2) , American Academy of Dermatology Annual Meeting: 2023
Sow Y, Wachuku C, Barrera T, Jackson T, Ayoade KO, Taylor SC, Mollanazar NK Palmer and Plantar Erythema: An Initial Presentation of Undifferentiated Connective Tissue Disease , JAAD Case Reports, 35: 2023,94-97
Wachuku C, Barrera T, Jackson T, Sow Y, Mollanazar NK, Taylor SC Upadacitinib, after failure with Dupilumab, as a treatment for chronic pruritus secondary to Polycythemia Vera , JAAD Case Rep, 35: 2023,87-89
Yosipovitch G, Mollanazar NK, Stander S, Kwatra SG, Kim BS, Laws E, Mannent LP, Amin N, Akinlade B, Wang S, Shi G, Patel K, Bansal A, O'Malley TJ Dupilumab Significantly Improves Itch and Skin Lesions in Patients With Prurigo Nodulras: Pooled Results From a 2nd Phase 3 Trail (LIBERTY-PN PRIME) , Hawaii Dermatology Seminar: 2023
Yosipovitch G, Kwatra SG, Mollanazar N, Stander S Satoh T, Laws E, Mannent LP, Mortensen E, Maloney J, Shi G, Bansal A, Martincova R Dupilumab Significantly Improves Itch and Skin Lesions in Patients With Prurigo Nodulras: Pooled Results From a 2nd Phase 3 Trails (LIBERTY-PN PRIME and PRIME2) , 4th San Diego Dermatology Symposium: 2023
Yosipovitch G, Kwatra SG, Mollanazar NK, Stander S Satoh T, Laws E, Mannent LP, Mortensen E, Maloney J, Shi G, Bansal E, Martincova R Dupilumab Significantly Improves Itch and Skin Lesions in Patients With Prurigo Nodulras: Pooled Results From Two Phase 3 Trails (LIBERTY-PN PRIME and PRIME 2) , Maui Derm Conference: 2023
Omar D, Brown-Korsah JB, Taylor SC, Mollanzar NK Automated Pharmacy substitution for medications not covered by medicaid: A model for reducing the burden of prior authorizations in dermatology , J AM Acad Dermatol, 88(1): 2023,258-60